NeuroBo Pharmaceuticals Inc (NRBO)
2.35
-0.05
(-2.08%)
USD |
NASDAQ |
Nov 21, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Enterprise Value: -1.421M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -1.421M |
| November 20, 2024 | -0.9906M |
| November 19, 2024 | -0.5598M |
| November 18, 2024 | -1.766M |
| November 15, 2024 | -2.542M |
| November 14, 2024 | -1.077M |
| November 13, 2024 | 0.388M |
| November 12, 2024 | 0.388M |
| November 11, 2024 | 1.336M |
| November 08, 2024 | 2.456M |
| November 07, 2024 | 1.422M |
| November 06, 2024 | 1.939M |
| November 05, 2024 | 0.2156M |
| November 04, 2024 | 0.1295M |
| November 01, 2024 | 1.317M |
| October 31, 2024 | 0.4561M |
| October 30, 2024 | 1.145M |
| October 29, 2024 | 2.953M |
| October 28, 2024 | 2.867M |
| October 25, 2024 | 2.264M |
| October 24, 2024 | 2.436M |
| October 23, 2024 | 2.694M |
| October 22, 2024 | 3.125M |
| October 21, 2024 | 3.469M |
| October 18, 2024 | 4.416M |
| Date | Value |
|---|---|
| October 17, 2024 | 5.535M |
| October 16, 2024 | 3.814M |
| October 15, 2024 | 0.1118M |
| October 14, 2024 | 0.1979M |
| October 11, 2024 | 0.37M |
| October 10, 2024 | -0.4048M |
| October 09, 2024 | 1.317M |
| October 08, 2024 | 1.145M |
| October 07, 2024 | 1.575M |
| October 04, 2024 | 1.834M |
| October 03, 2024 | 1.145M |
| October 02, 2024 | 1.489M |
| October 01, 2024 | 3.555M |
| September 30, 2024 | 5.622M |
| September 27, 2024 | 0.2422M |
| September 26, 2024 | -0.0124M |
| September 25, 2024 | 0.2422M |
| September 24, 2024 | -0.7762M |
| September 23, 2024 | -0.8611M |
| September 20, 2024 | -0.8611M |
| September 19, 2024 | -0.267M |
| September 18, 2024 | 0.9211M |
| September 17, 2024 | 1.176M |
| September 16, 2024 | 1.261M |
| September 13, 2024 | 2.703M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.46M
Minimum
Jun 23 2023
454.09M
Maximum
Feb 12 2020
41.08M
Average
5.580M
Median
Enterprise Value Benchmarks
| Dermata Therapeutics Inc | -3.797M |
| Cognition Therapeutics Inc | -3.738M |
| ZyVersa Therapeutics Inc | 2.550M |
| Cytokinetics Inc | 5.270B |
| Ocugen Inc | 226.64M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.652M |
| Total Expenses (Quarterly) | 6.259M |
| EPS Diluted (Quarterly) | -0.55 |
| Earnings Yield | -203.0% |